Axial Biotherapeutics and Parkinson’s Institute Partner to Study GI Metabolites That May Contribute to Parkinson’s Disease

Parkinson’s Institute and Clinical Center (PICC) and Axial Biotherapeutics announced today a collaboration to investigate interventions targeting gastrointestinal (GI) metabolites that may cause Parkinson’s Disease (PD).